← Back to Search

Evidence-Based Practice Education for Dizziness (DIZZTINCT2 Trial)

N/A
Recruiting
Led By Kevin Kerber, MD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English or Spanish speaker
Age >= 18 years
Must not have
Does not demonstrate capacity to consent assessed by the Older Adults' Capacity to Consent to Research (OACCR) scale48
Level 1 trauma diagnosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up cumulative 4 weeks following index ed visit
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to improve the care of patients with dizziness in emergency departments by educating doctors and patients about the best practices for diagnosis and treatment. Doctors will receive training through online courses, websites, and printed materials, while patients will get personalized information through a website. The goal is to reduce unnecessary tests and ensure effective treatment.

Who is the study for?
This trial is for adults over 18 who've been discharged from certain emergency departments in the last 48 hours with a primary diagnosis of dizziness or related vestibular disorders. Participants must be Kaiser Permanente members, speak English or Spanish, and able to consent. Those with severe trauma, previous study enrollment, or inability to consent are excluded.
What is being tested?
The study tests how well evidence-based practices for managing dizziness (like BPPV) are implemented in emergency departments. It uses an enhanced strategy developed from prior research and assesses its effectiveness through a stepped-wedge design and randomized patient-level dissemination.
What are the potential side effects?
Since this trial focuses on educational interventions rather than medications, traditional side effects aren't expected. However, participants may experience discomfort or anxiety when discussing medical conditions or during assessments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I speak English or Spanish.
Select...
I am 18 years old or older.
Select...
I was diagnosed with dizziness or balance issues as my main health problem.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am able to understand and agree to participate in research.
Select...
I have been diagnosed with a major injury.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~cumulative 4 weeks following index ed visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and cumulative 4 weeks following index ed visit for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Dizziness Handicap Inventory
Documentation of Dix-Hallpike Test/Canalith Repositioning Maneuver

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

6Treatment groups
Experimental Treatment
Active Control
Group I: Group 6: Post-CME with Chart Review OnlyExperimental Treatment1 Intervention
Physicians in hospitals that have received the DIZZTINCT educational intervention. Eligible patient will have their medical records abstracted to assess the main study outcome
Group II: Group 5: Post-CME with Standard Patient CareExperimental Treatment1 Intervention
Physicians in hospitals that have received the DIZZTINCT educational intervention. Patients have not receive the DIZZTINCT educational intervention
Group III: Group 4: Post-CME with Patient EducationExperimental Treatment2 Interventions
Physicians in hospitals that have received the DIZZTINCT educational intervention. Patients have receive the DIZZTINCT educational intervention
Group IV: Group 1: Pre-CME with Patient EducationExperimental Treatment1 Intervention
Physicians in hospitals that have not received the DIZZTINCT educational intervention. Patients have received the DIZZTINCT educational intervention
Group V: Group 2: Pre-CME with Standard Patient CareActive Control1 Intervention
Physicians in hospitals that have not received the DIZZTINCT educational intervention. Patients have not received the DIZZTINCT educational intervention
Group VI: Group 3: Pre-CME with Chart Review OnlyActive Control1 Intervention
Physicians in hospitals that have not received the DIZZTINCT educational intervention. Eligible patient will have their medical records abstracted to assess the main study outcome

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for vertigo, particularly benign paroxysmal positional vertigo (BPPV), include canalith repositioning maneuvers such as the Epley maneuver. These maneuvers work by moving the dislodged calcium carbonate crystals (canaliths) from the semicircular canals of the inner ear back to their correct location in the utricle, where they can no longer cause vertigo symptoms. This is crucial for vertigo patients as it directly addresses the root cause of BPPV, providing rapid and effective symptom relief. Additionally, vestibular rehabilitation therapy (VRT) is used to improve balance and reduce dizziness through exercises that promote central nervous system compensation for inner ear deficits. Implementing these evidence-based practices effectively can significantly enhance patient outcomes and reduce the burden of vertigo.
Meta-analyses of randomized controlled trials.No short-cut in assessing trial quality: a case study.

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
869 Previous Clinical Trials
574,976 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
354 Previous Clinical Trials
101,727 Total Patients Enrolled
5 Trials studying Vertigo
8,552 Patients Enrolled for Vertigo
Kaiser PermanenteOTHER
554 Previous Clinical Trials
27,651,754 Total Patients Enrolled
1 Trials studying Vertigo

Media Library

Group 6: Post-CME with Chart Review Only Clinical Trial Eligibility Overview. Trial Name: NCT05634902 — N/A
Vertigo Research Study Groups: Group 2: Pre-CME with Standard Patient Care, Group 6: Post-CME with Chart Review Only, Group 1: Pre-CME with Patient Education, Group 3: Pre-CME with Chart Review Only, Group 4: Post-CME with Patient Education, Group 5: Post-CME with Standard Patient Care
Vertigo Clinical Trial 2023: Group 6: Post-CME with Chart Review Only Highlights & Side Effects. Trial Name: NCT05634902 — N/A
Group 6: Post-CME with Chart Review Only 2023 Treatment Timeline for Medical Study. Trial Name: NCT05634902 — N/A
~3077 spots leftby Jan 2025